Inova’s Breast Cancer Team Takes a New Look at Hormone Therapy Treatment

A group of six Inova physicians have published a paper in the Annals of Surgical Oncology that could lead to re-thinking of treatment  practices for individuals with breast cancer. The paper, published in November 2020, details the results of a systemic literature review that included over 6,000 patient cases.

READ THE REPORT: Axillary Response in Patients Undergoing Neoadjuvant Endocrine Treatment for Node-Positive Breast Cancer: Systematic Literature Review and NCDB Analysis (Nov. 2020)

On review of the national database the team found that although endocrine therapy (also called “hormone therapy”)  works more slowly and so has not been used as much particularly in higher risk patients with positive axillary nodes, it had a very good success rate achieving a 14.4% pathologic complete response in clearing the axilla in patients with positive axillary nodes. This was higher than the success rate that was seen in previous smaller studies.

The team’s findings offer evidence that hormone therapy may offer a higher rate of success than previously believed, which could lead to it being offered more often to patients as a potential treatment option.

The researchers evaluated the impact of neoadjuvant endocrine therapy (NET) on axillary downstaging and surgical management. After a systemic review of the literature, the researchers discovered that patients who underwent neoadjuvant endocrine therapy for “node positive” (N+) breast cancer had a higher axillary pathologic complete response (pCR)* than previously reported in smaller studies. 

  * “Pathologic complete response” refers to an outcome whereby a patient who was given some form of therapy prior to surgery is then shown to have no cancer cells present in tissues that, prior to the therapy and surgery, did contain cancer cells.

Contributors from Inova:

  • Kirsten Edmiston, MD (Inova Medical Group – Breast Surgery, Inova Schar Cancer Institute)
  • Costanza Cocilovo, MD (Inova Medical Group – Breast Surgery, Inova Schar Cancer Institute)
  • Sara Bruce, MD (Inova Breast Care Institute/ Inova Alexandria Hospital)
  • Arielle Stafford (Surgical Chief Resident, Inova)
  • Robert Cohen, MD

Inova Newsroom

Share
Published by
Inova Newsroom

Recent Posts

State-of-the-art healthcare facility opening in November

Inova celebrates new Inova Health Center – Oakville with ribbon cutting Local officials, community members,…

5 days ago

Inova Loudoun Mobile Health Services: November 2024

Leesburg, VA, October 24, 2024 — Inova Loudoun Hospital Mobile Health Services will be providingcountywide…

1 week ago

Baxter IV shortage: Inova’s immediate recommendations for urology practices

The Impact of Hurricane Helene Destruction of Baxter Factory: Immediate Recommendations for Urology Practices in…

3 weeks ago

Inova L.J. Murphy Children’s Hospital Ranks in Top 40 Best Children’s Hospitals for Neonatology by U.S. News & World Report

Fairfax, VA – Oct. 8, 2024 – Inova L.J. Murphy Children’s Hospital has been recognized…

4 weeks ago

Inova Names John Moynihan, MD, President and Chief, Clinical Enterprise

Fairfax, VA – Oct. 4, 2024 – After an expansive national search, Inova is pleased…

1 month ago

Debunking breast cancer myths

Costanza Cocilovo, MD, FACS is board certified in surgery and fellowship trained in breast surgery.…

1 month ago